Structure-activity relationship study on α1 adrenergic receptor antagonists from beer

被引:22
|
作者
Wakimoto, Toshiyuki [1 ,2 ]
Nitta, Makoto [1 ,2 ]
Kasahara, Kana [1 ,2 ]
Chiba, Taketo [1 ,2 ]
Ye Yiping [1 ,2 ]
Tsuji, Kuniro [1 ,2 ]
Kan, Toshiyuki [1 ,2 ]
Nukaya, Haruo [1 ,2 ]
Ishiguro, Masaji [3 ]
Koike, Minako [4 ]
Yokoo, Yoshiaki [4 ]
Suwa, Yoshihide [4 ]
机构
[1] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan
[2] Global COE Program, Suruga Ku, Shizuoka 4228526, Japan
[3] Suntory Inst Bioorgan Res, Shimamoto, Osaka 6188503, Japan
[4] Suntory Holdings Ltd, Tech Dev Dept, Shimamoto, Osaka 6180001, Japan
关键词
Hordatine A; Aperidine; Absolute stereochemistry; alpha 1A adrenoceptor; BINDING; CONFIGURATION; SUBTYPES; SITES;
D O I
10.1016/j.bmcl.2009.08.068
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Hordatine A and aperidine have been previously isolated from beer as active ingredients, which bind to muscarinic M-3 receptor. In addition, these compounds have exhibited antagonist activity against the alpha(1A) adrenoceptor. Although the relative structures of these two molecules have previously been determined, the absolute stereochemistry was unclear. Hence, to elucidate the absolute stereochemistry of natural hordatine A, we synthesized each enantiomer of hordatine A and aperidine from optically pure dehydrodi-p-coumaric acid. Several additional related compounds were also synthesized for structure-activity relationship studies. Chiral column HPLC analysis demonstrated that the absolute stereochemistry of natural hordatine A is (2S,3S), while based on the isomerization mechanism, the stereochemistry of aperidine is (2R,3S). The alpha(1A) adrenoceptor binding activity of (2R,3R)-hordatine A is the most potent among the enantiomeric pairs of hordatines and aperidines. Furthermore, the related, synthetic compound, (2R,3R)-methyl benzofurancarboxylate exhibits antagonist activity against the alpha(1A) adrenoceptor at a lower concentration than that of hordatine A. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5905 / 5908
页数:4
相关论文
共 50 条
  • [31] DESIGN, SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES FOR IMIDAZOLYL QUINOXALINES AS AMPA RECEPTOR ANTAGONISTS
    OHMORI, J
    SHIMIZUSASAMATA, S
    OKADA, M
    SAKAMOTO, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 178 - MEDI
  • [32] A Combined Quantitative Structure-Activity Relationship Research of Quinolinone Derivatives as Androgen Receptor Antagonists
    Wang, Yuwei
    Bai, Fang
    Cao, Hong
    Li, Jiazhong
    Liu, Huanxiang
    Gramatica, Paola
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2015, 18 (09) : 834 - 845
  • [33] PHARMACOLOGICAL STUDIES ON STRUCTURE-ACTIVITY RELATIONSHIP OF MORPHINE ANTAGONISTS
    ANAND, DR
    ARZNEIMITTEL-FORSCHUNG, 1965, 15 (05): : 564 - &
  • [34] Quantitative structure-activity relationship studies on cholecystokinin antagonists
    Gupta, SP
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (02) : 111 - 124
  • [35] Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists
    Zhao, HY
    Xi, ZL
    Patel, JR
    Nelson, LTJ
    Liu, B
    Szczepankiewicz, BG
    Schaefer, VG
    Falls, HD
    Kaszubska, W
    Collins, CA
    Sham, HL
    Liu, G
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (07) : 1825 - 1828
  • [36] Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists
    Doller, D
    Chackalamannil, S
    Czarniecki, M
    McQuade, R
    Ruperto, V
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (06) : 901 - 906
  • [37] Structure-activity relationships of competitive NMDA receptor antagonists
    Cheung, NS
    OCallaghan, D
    Ryan, MC
    Dutton, R
    Wong, MG
    Beart, PM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 313 (1-2) : 159 - 162
  • [38] Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists
    Ahn, HS
    Arik, L
    Boykow, G
    Burnett, DA
    Caplen, MA
    Czarniecki, M
    Domalski, MS
    Foster, C
    Manna, M
    Stamford, AW
    Wu, YS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (14) : 2073 - 2078
  • [39] Androgen receptor antagonists (antiandrogens): Structure-activity relationships
    Singh, SM
    Gauthier, S
    Labrie, F
    CURRENT MEDICINAL CHEMISTRY, 2000, 7 (02) : 211 - 247
  • [40] Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists
    Zarrinmayeh, H
    Zimmerman, DM
    Cantrell, BE
    Schober, DA
    Bruns, RF
    Gackenheimer, SL
    Ornstein, PL
    Hipskind, PA
    Britton, TC
    Gehlert, DR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (05) : 647 - 652